A Phase II Trial of Albumin-Bound Paclitaxel and Gemcitabine in Patients With Untreated Stage IV or Recurrent Squamous Cell Lung Cancers
Phase of Trial: Phase II
Latest Information Update: 25 May 2017
At a glance
- Drugs Paclitaxel (Primary) ; Gemcitabine
- Indications Lung cancer
- Focus Therapeutic Use
- 23 Jan 2017 Planned End Date changed from 1 Aug 2017 to 1 Aug 2018.
- 23 Jan 2017 Planned primary completion date changed from 1 Aug 2017 to 1 Aug 2018.
- 21 Aug 2015 New trial record